Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Patient Priorities Aligned Discrete Decision Making for Older Adults With Multiple Chronic Conditions.

21 de octubre de 2026 actualizado por: Aanand Dinkar Naik, The University of Texas Health Science Center, Houston

The purpose of the study is to to evaluate an artificial intelligence (AI) powered large language model (LLM) chatbot -PrioritiesAI -that assists patients in understanding, clarifying, and communicating their health priorities and desired outcomes related to elective hernia surgery.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

80

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Texas
      • Houston, Texas, Estados Unidos, 77030
        • Reclutamiento
        • The University of Texas Health Science Center at Houston
        • Contacto:
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

60 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Capacity to provide informed consent
  • Ability to communicate effectively by phone in English
  • Access to a working email address that the participant checks regularly
  • Scheduled for an upcoming outpatient consultation with one of our partner surgeons to discuss elective hernia surgery (femoral, ventral, inguinal, or umbilical)
  • No significant cognitive impairment that would interfere with meaningful participation

To ensure focus on surgical decisions, participants must fall into one of these categories:

  1. Patients scheduled for an upcoming outpatient consultation with one of our partner surgeons specifically to discuss a potential surgical procedure
  2. Patients who have undergone a surgical procedure performed one of our partner surgeons after January 1, 2025
  3. Participants must meet criteria #1 or #2 above and must not have participated in Phase 1 of the study

Exclusion Criteria:

  • Cognitive impairment sufficient to interfere with meaningful participation in Patient Priorities Care (PPC) discussions
  • Communication challenges that cannot be reasonably accommodated within the study protocol
  • Inability to complete patient-reported outcome measures independently or with minimal assistance
  • Lack of decision-making capacity regarding surgical care

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Brazo de control
Experimental: AI Chatbot

Participants receive a personalized web link by email .The link provides access to the Priorities AI chatbot on any internet-connected device. The chatbot guides participants through a structured conversation to identify their health priorities and goals related to their surgical decision,

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Decision regret as assessed by the Decision regret scale
Periodo de tiempo: 4 months after surgery

This is a 5 item questionnaire and each is scored from 0(no regret)-5 (high regret). Average of the item scores are calculated then 1 is subtracted and the final score is multiplied by 25 for a final metric from 0 to 100. Higher scores indicating worse outcome

4 months after surgery
Self-identified health goals following elective hernia surgery, as measured by the Goal Attainment Scale (GAS)
Periodo de tiempo: 4 months after surgery

This is rated on a 5-point scale from -2 (much less than expected) to +2 (much better than expected), with 0 representing the expected level of goal attainment. Higher scores indicate greater attainment of individualized goals.

4 months after surgery

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Decision-making quality in surgical consultations using the Shared Decision-Making Process (SDMP)Scale
Periodo de tiempo: 24 hours-72 hours after the intervention

The Shared Decision-Making Process (SDMP) Scale is a 4-item, patient-reported measure. Maximum scores range from 0 to 4, with higher scores indicating greater shared decision-making.

24 hours-72 hours after the intervention
Perceived involvement in care using the Perceived Involvement in Care Scale (PICS, binary format)
Periodo de tiempo: 24 hours-72 hours after the intervention

This is a 13 item questionnaire and each is scored as 1(agree) or 0(disagree) for a total score 0-13, with higher scores indicating greater perceived involvement in care.

24 hours-72 hours after the intervention
Decisional confidence using the SURE scale
Periodo de tiempo: 24 hours-72 hours after the intervention

This is a 4 item questionnaire and each is scored as a 1(yes) or 0(no) for a maximum score of 0-4,higher score indicating greater decisional confidence

24 hours-72 hours after the intervention
Acceptability as assessed by the Acceptability of Intervention Measure (AIM)
Periodo de tiempo: 24 hours-72 hours after the intervention

This is a 4 item questionnaire and each is scored on a 5-point Likert scale from 1( completely disagree) to 5 (completely agree) for a maximum score of 4-20, higher scores indicate greater perceived acceptability

24 hours-72 hours after the intervention
Appropriateness as assessed by the Intervention Appropriateness Measure (IAM)
Periodo de tiempo: 24 hours-72 hours after the intervention

This is a 4 item questionnaire and each is scored on a 5-point Likert scale from 1( completely disagree) to 5 (completely agree) for a maximum score of 4-20, higher scores indicate greater perceived appropriateness

24 hours-72 hours after the intervention
Feasibility as assessed by the Feasibility of Intervention Measure (FIM)
Periodo de tiempo: 24 hours-72 hours after the intervention

This is a 4 item questionnaire and each is scored on a 5-point Likert scale from 1( completely disagree) to 5 (completely agree) for a maximum score of 4-20, higher scores indicate greater perceived feasibility

24 hours-72 hours after the intervention
Assigned preparation approach on health-related quality of life using the Short Form (SF-12) Quality of Life Scale
Periodo de tiempo: 4 months after surgery

The SF-12 assesses physical and mental health across eight health concepts and generates two summary scores: the Physical Component Summary (PCS-12) and Mental Component Summary (MCS-12). Both scores are calculated using responses to all 12 items and are typically reported on a 0-100 scale, with higher scores indicating better health-related quality of life.

4 months after surgery
Comfort and function following surgery using the Carolina's Comfort Scale (CCS)
Periodo de tiempo: 4 months after surgery

This is a 23 item questionnaire and each is scored from 0(no symptoms) to 5( disabling symptoms) for a score range of 0-115, higher score indicating worse postoperative comfort

4 months after surgery
Satisfaction as assessed by the Satisfaction Measure
Periodo de tiempo: 24 hours-72 hours after the intervention

This is a 1 item questionnaire and scored from 0(worst visit possible)-10 ( best visit possible) , higher value means better outcome

24 hours-72 hours after the intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Aanand D Naik, MD, The University of Texas Health Science Center, Houston

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

30 de abril de 2026

Finalización primaria (Estimado)

30 de octubre de 2027

Finalización del estudio (Estimado)

30 de octubre de 2027

Fechas de registro del estudio

Enviado por primera vez

22 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

22 de septiembre de 2026

Publicado por primera vez (Actual)

30 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

26 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

21 de octubre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • HSC-SPH-22-0586

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir